Results 211 to 220 of about 1,352,188 (295)

Distribution of E. coli and extended-spectrum beta-lactamase-producing E. coli isolates from dogs and/or cats specimens submitted for microbiological analysis included in the studies.

open access: green
Rasaq A. Ojasanya (13984827)   +5 more
openalex   +1 more source

Analysis of Patients With Monocytic and Monocytic‐Like Acute Myeloid Leukemia, Including AML‐M4 and AML‐M5, Treated With Venetoclax Plus Azacitidine

open access: yes
American Journal of Hematology, EarlyView.
Marina Konopleva   +8 more
wiley   +1 more source

Creative Futures in Education: Building 'Imagination Infrastructures' for Microbiology and Beyond. [PDF]

open access: yesMicrob Biotechnol
Robinson JM   +5 more
europepmc   +1 more source

Basiliximab in the Prophylaxis of aGVHD for Unrelated Donor Hematopoietic Stem Cell Transplantation in Patients With Thalassemia Major: A Prospective, Multicenter, Open‐Label, Randomized Controlled Study

open access: yes
American Journal of Hematology, EarlyView.
Zhenbin Wei   +19 more
wiley   +1 more source

A Murine Bispecific Antibody Efficiently Redirects T Cells Against Calr Mutated Stem Cells In Vivo

open access: yesAmerican Journal of Hematology, EarlyView.
ABSTRACT Calreticulin (CALR) mutations are prevalent in 20%–30% of patients with BCR::ABL1‐negative myeloproliferative neoplasms (MPN). Mutant calreticulin (mutCALR), presented by the thrombopoietin receptor (MPL, also known as TPOR or CD110) on the surface of the disease‐initiating MPN progenitors, represents an ideal target for curative ...
Shengen Xiong   +5 more
wiley   +1 more source

Activity of cefepime/enmetazobactam against highly multidrug-resistant bacterial isolates recovered from war-associated wounds in Ukraine. [PDF]

open access: yesJAC Antimicrob Resist
Boral J   +7 more
europepmc   +1 more source

Autosomal Dominant Erythrocytosis Caused by Non‐Renal Erythropoietin (EPO) Due to EPO c.‐136 G>A Germline Mutation

open access: yesAmerican Journal of Hematology, EarlyView.
A novel erythropoietin (EPO) promoter mutation (c.‐136 G>A) causes autosomal dominant erythrocytosis via non‐renal expression of EPO. ABSTRACT We previously reported a five‐generation kindred with autosomal dominant erythrocytosis associated with a novel germline promoter variant in the erythropoietin (EPO) gene (EPO c.‐136 G>A).
Lucie Lanikova   +10 more
wiley   +1 more source

Perspectives on the future of the profession of microbiology. [PDF]

open access: yesmSphere
Kelson TL   +13 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy